ZEB1 and hepatocellular carcinoma: Sreekumar et al. demonstrated that the positive rate of ZEB1 was about 5% (1/19) in patients with TNM stage 1 or 2 HCC, while it was about 47.6% (10/21) in patients with TNM stage 3 HCC 16.